Top compounds associated with response to HAL


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.31 2e-23
mRNA ATRA CTRPv2 pan-cancer AAC 0.28 3e-17
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.39 4e-15
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-11
mRNA PD318088 CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA Sorafenib CCLE pan-cancer AAC 0.28 5e-10
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 1e-09
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.18 2e-08
mRNA linifanib GDSC1000 pan-cancer AAC 0.19 3e-08
mRNA AC220 GDSC1000 pan-cancer AAC 0.19 6e-08
Download CSV